Covington facilitates US biotech player’s AIM float
Covington & Burling has scored the lead advisory role on the AIM listing of US biotechnology company Northwest Biotherapeutics. Corporate partner Simon Amies led the team acting for Northwest alongside US securities partner Peter Laveran. According to Laveran the listing was complicated as the company was already quoted on the US OTC Bulletin Board exchange, […]